Biora Therapeutics, Inc. (BIORQ)
OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0030 (-99.97%)
Aug 18, 2025, 4:00 PM EDT
Biora Therapeutics Revenue
Biora Therapeutics had revenue of $32.00K in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $892.00K, up 4,855.56% year-over-year. In the year 2023, Biora Therapeutics had annual revenue of $4.00K, down -98.69%.
Revenue (ttm)
892.00K
Revenue Growth
+4,855.56%
P/S Ratio
n/a
Revenue / Employee
15.38K
Employees
58
Market Cap
4.00
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 4.00K | -301.00K | -98.69% |
Dec 31, 2022 | 305.00K | -942.00K | -75.54% |
Dec 31, 2021 | 1.25M | 1.09M | 669.75% |
Dec 31, 2020 | 162.00K | -143.82M | -99.89% |
Dec 31, 2019 | 143.99M | 16.01M | 12.51% |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Federal National Mortgage Association | 28.89B |
Alpine Banks of Colorado | 250.10M |
Federal Home Loan Mortgage | 22.97B |
Thai Airways International Public Company | 5.84B |
Alpine Auto Brokers | 129.78K |
Central Bancompany | 851.25M |
First National of Nebraska | 1.89B |
Jingbo Technology | 2.29M |
Biora Therapeutics News
- 9 months ago - Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 10 months ago - Biora Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update - GlobeNewsWire
- 10 months ago - Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 10 months ago - Biora Therapeutics Shares Progress on Smaller BioJet™ Clinical Device with Largest Payload of any Ingestible Injectable at the 14th Annual PODD Meeting - GlobeNewsWire
- 1 year ago - Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 1 year ago - Biora Therapeutics, Inc. (BIOR) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 1 year ago - Biora Therapeutics Announces Funding Agreement with Existing Investors - GlobeNewsWire